Sandbox:Shivam Singla: Difference between revisions

Jump to navigation Jump to search
(Created blank page)
 
No edit summary
Line 1: Line 1:
== '''<big>COVID - 19</big>''' ==
'''Editor-In-Chief:''' [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] [[Mailto:charlesmichaelgibson@gmail.com|[1]]]
<br />


== Historical Perspective ==
* COVID -19 was first identified in Wuhan, China with a global spread resulting in on going pandemic.
* Till 4th May 2020, more than 3.52 million cases have been reported across 187 countries worldwide.
<br />
== Classification[edit | edit source] ==
* [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
:* [group1]
:* [group2]
:* [group3]
* Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
== Pathophysiology[edit | edit source] ==
* The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
* The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
* On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
* On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
== Clinical Features[edit | edit source] ==
== Differentiating [disease name] from other Diseases[edit | edit source] ==
* [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
:* [Differential dx1]
:* [Differential dx2]
:* [Differential dx3]
== Epidemiology and Demographics[edit | edit source] ==
* The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
* In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
=== Age[edit | edit source] ===
* Patients of all age groups may develop [disease name].
* [Disease name] is more commonly observed among patients aged [age range] years old.
* [Disease name] is more commonly observed among [elderly patients/young patients/children].
=== Gender[edit | edit source] ===
* [Disease name] affects men and women equally.
* [Gender 1] are more commonly affected with [disease name] than [gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
=== Race[edit | edit source] ===
* There is no racial predilection for [disease name].
* [Disease name] usually affects individuals of the [race 1] race.
* [Race 2] individuals are less likely to develop [disease name].
== Risk Factors[edit | edit source] ==
* Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
== Natural History, Complications and Prognosis[edit | edit source] ==
* The majority of patients with [disease name] remain asymptomatic for [duration/years].
* Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
* If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
* Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
* Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].
== Diagnosis[edit | edit source] ==
=== Diagnostic Criteria[edit | edit source] ===
* The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
:* [criterion 1]
:* [criterion 2]
:* [criterion 3]
:* [criterion 4]
=== Symptoms[edit | edit source] ===
* [Disease name] is usually asymptomatic.
* Symptoms of [disease name] may include the following:
:* [symptom 1]
:* [symptom 2]
:* [symptom 3]
:* [symptom 4]
:* [symptom 5]
:* [symptom 6]
=== Physical Examination[edit | edit source] ===
* Patients with [disease name] usually appear [general appearance].
* Physical examination may be remarkable for:
:* [finding 1]
:* [finding 2]
:* [finding 3]
:* [finding 4]
:* [finding 5]
:* [finding 6]
=== Laboratory Findings[edit | edit source] ===
* There are no specific laboratory findings associated with [disease name].
* A [positive/negative] [test name] is diagnostic of [disease name].
* An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
* Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
=== Imaging Findings[edit | edit source] ===
* There are no [imaging study] findings associated with [disease name].
* [Imaging study 1] is the imaging modality of choice for [disease name].
* On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
* [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
=== Other Diagnostic Studies[edit | edit source] ===
* [Disease name] may also be diagnosed using [diagnostic study name].
* Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
== Treatment[edit | edit source] ==
=== Medical Therapy[edit | edit source] ===
* There is no treatment for [disease name]; the mainstay of therapy is supportive care.
* The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
* [Medical therapy 1] acts by [mechanism of action 1].
* Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
=== Surgery[edit | edit source] ===
* Surgery is the mainstay of therapy for [disease name].
* [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
* [Surgical procedure] can only be performed for patients with [disease stage] [disease name].
=== Prevention[edit | edit source] ===
* There are no primary preventive measures available for [disease name].
* Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
* Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
== References[edit | edit source] ==
[[Special:Categories|Category]]:
* Pick One of 28 Approved
----'''Navigation''' [[Main Page|WikiDoc]] | [[WikiPatient]] | [[:Category:Up-To-Date|Up To Date Pages]] | [[Special:RecentChanges|Recently Edited Pages]] | [[Special:NewFiles|Recently Added Pictures]]
'''Table of Contents''' [[Special:AllPages|In Alphabetical Order]] | [[:Category:List of Diseases|By Individual Diseases]] | [[The WikiDoc Living Textbook of Signs and Symptoms|Signs and Symptoms]] | [[The WikiDoc Living Textbook of Physical Examination|Physical Examination]] | [[The WikiDoc Living Textbook of Laboratory Findings|Lab Tests]] | [[The WikiDoc Living Textbook of Pharmacology|Drugs]]
'''Editor Tools''' [[NewPage|Create a New Page]] | [[Editor Application|Become an Editor]] | [[Help Menu|Editors Help Menu]] | [[Firstpage|Create a Page]] | [[Help:Editing|Edit a Page]] | [[Special:Upload|Upload a Picture or File]] | Printable version | [[Special:SpecialPages|Maintain Pages]] | [[Special:WhatLinksHere|What Pages Link Here]] | [[Index.php/WikiDoc Quality Improvement Project|Quality Improvement]]
Introduction

Revision as of 13:43, 4 May 2020

COVID - 19

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [[1]]

Historical Perspective

  • COVID -19 was first identified in Wuhan, China with a global spread resulting in on going pandemic.
  • Till 4th May 2020, more than 3.52 million cases have been reported across 187 countries worldwide.


Classification[edit | edit source]

  • [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
  • [group1]
  • [group2]
  • [group3]
  • Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology[edit | edit source]

  • The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
  • The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Clinical Features[edit | edit source]

Differentiating [disease name] from other Diseases[edit | edit source]

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
  • [Differential dx1]
  • [Differential dx2]
  • [Differential dx3]

Epidemiology and Demographics[edit | edit source]

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age[edit | edit source]

  • Patients of all age groups may develop [disease name].
  • [Disease name] is more commonly observed among patients aged [age range] years old.
  • [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender[edit | edit source]

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected with [disease name] than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race[edit | edit source]

  • There is no racial predilection for [disease name].
  • [Disease name] usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop [disease name].

Risk Factors[edit | edit source]

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis[edit | edit source]

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis[edit | edit source]

Diagnostic Criteria[edit | edit source]

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms[edit | edit source]

  • [Disease name] is usually asymptomatic.
  • Symptoms of [disease name] may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination[edit | edit source]

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings[edit | edit source]

  • There are no specific laboratory findings associated with [disease name].
  • A [positive/negative] [test name] is diagnostic of [disease name].
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings[edit | edit source]

  • There are no [imaging study] findings associated with [disease name].
  • [Imaging study 1] is the imaging modality of choice for [disease name].
  • On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies[edit | edit source]

  • [Disease name] may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment[edit | edit source]

Medical Therapy[edit | edit source]

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery[edit | edit source]

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention[edit | edit source]

  • There are no primary preventive measures available for [disease name].
  • Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References[edit | edit source]

Category:

  • Pick One of 28 Approved

Navigation WikiDoc | WikiPatient | Up To Date Pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs Editor Tools Create a New Page | Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Maintain Pages | What Pages Link Here | Quality Improvement


Introduction